injectable ghk-cu clinical trial Peptides for Anti-Aging? A Dermatologist Explains GHK-Cu Peptide Injection Before and

Human trials remain scarce

ACL reconstruction studies in rats using articular injection of 0.3 mg/ml GHK-Cu enhanced healing outcomes

ARDS is linked with injury and infection

Carcinogenesis 35 , 967973 (2014)

In summary: BPC-157 is a promising compound for different cytoprotective uses It is not FDA approved for human use There is not some shadow cabal blocking the use of BPC-157 - Financial incentives make it so that BPC-157 is challenging to push through the regulatory process - It will likely never receive FDA approval, but will be available in some form as oral supplement or through compounding pharmacies, with some modification This is not medical advice